Qube Research & Technologies LTD Ani Pharmaceuticals Inc Transaction History
Qube Research & Technologies LTD
- $61.9 Billion
- Q1 2024
A detailed history of Qube Research & Technologies LTD transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 117,526 shares of ANIP stock, worth $7.22 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
117,526
Previous 104,235
12.75%
Holding current value
$7.22 Million
Previous $5.75 Million
41.36%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding ANIP
# of Institutions
206Shares Held
14MCall Options Held
26.7KPut Options Held
237K-
Black Rock Inc. New York, NY2.53MShares$156 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.31MShares$80.3 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY959KShares$58.9 Million2.26% of portfolio
-
Deep Track Capital, LP Greenwich, CT822KShares$50.5 Million1.88% of portfolio
-
Dimensional Fund Advisors LP Austin, TX609KShares$37.4 Million0.01% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.07B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...